Pallas Health vs Eden Health: Pricing, meds, and clinician care
Pallas Health vs Eden Health: quick verdict. If you want clinician choice between FDA-approved pens and US-compounded GLP-1s with an all-in plan price, Pallas Health emphasizes that model. If you prefer a fixed monthly price guaranteed for life with straightforward monthly billing, Eden Health highlights that approach.
Explore Pallas Health plans and clinician-reviewed options
Top distinctions at a glance
This comparison focuses on the most distinctive supported differences between Pallas Health and Eden Health: pricing structure and billing cadence, medication options and regulatory notes, clinician involvement and care model, shipping and renewal terms, and which patients each provider may suit best.
Pricing structure and billing cadence
Pallas Health offers compounded semaglutide starting at $139 for the first month and then $597 every 12 weeks, described as a $199 per month average. Compounded tirzepatide is $179 first month then $897 every 12 weeks, a $299 per month average. Pallas also lists cash-pay brand-name prices for Wegovy, Ozempic, Zepbound and Mounjaro at specific monthly cash rates. Pallas is cash-pay only and does not bill insurance. Eden Health presents monthly pricing at every dose: semaglutide at $99 and tirzepatide at $129, with a lifetime price guarantee and no membership fees. Eden emphasizes one monthly price, guaranteed for life.
See Eden Health monthly pricing and lifetime price guarantee
Medication options and regulatory notes
Pallas Health offers both FDA-approved brand-name GLP-1s and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. The source notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Pallas states that compounded plans are priced by medication rather than by milligram so titration does not raise the plan price. Eden Health advertises semaglutide and tirzepatide pricing and says medication-specific approval status must be confirmed; it notes branded and compounded products are not interchangeable. Eden also states treatment is available only when a licensed clinician determines it is medically appropriate, and that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Compare Pallas brand and compounded GLP-1 options
Care model, clinician review, and access
Pallas Health is 100 percent online with a US-licensed clinician reviewing health history to personalize the plan. Pallas states provider care, check-ins and messaging are included in the plan price with no membership fee, and that most states are asynchronous (43 of 50 need no video visit) while seven states plus Washington, D.C. require a video visit. Eden Health describes a doctor-guided GLP-1 program with clinician review and a guided program built around the user; the captured evidence emphasizes clinician determination of medical appropriateness. Eden claims it brings medication, care and support together under one monthly price. Specific hours, refund policy, or state-by-state visit requirements for Eden were not supplied in the captured evidence.
Shipping, renewals, and cancellation notes
Both providers advertise free expedited shipping. Pallas notes free and discreet shipping on every plan and that compounded plans renew every 12 weeks, so cancellation timing matters; Pallas also notes plans include provider messaging and cancel-anytime access. Eden emphasizes free expedited shipping and no membership fees, and states a lifetime price guarantee; the captured evidence warns pricing, eligibility, pharmacy, state coverage and renewal terms may change. Specific cancellation windows for Eden were not supplied in the captured evidence.
Comparison table
| Criteria | Pallas Health | Eden Health |
|---|---|---|
| Starting price | $139 first month (compounded semaglutide) | $99 monthly (semaglutide) |
| Billing cadence | Compounded plans renew every 12 weeks (first-month intro then 12-week renewals) | Monthly pricing at every dose, lifetime price guarantee |
| Medication options | FDA-approved brand-name options plus US-compounded semaglutide and tirzepatide | Semaglutide and tirzepatide offered; approval status to be confirmed |
| Clinician review | US-licensed clinician reviews health history; care included in plan price | Treatment available only when a licensed clinician determines it is medically appropriate |
| Regulatory note | Compounded meds are not FDA-approved and not reviewed by FDA | Compounded meds, when offered, are not FDA-approved and not reviewed by FDA |
| Shipping | Free expedited and discreet shipping | Free expedited shipping |
Who each provider is best for
Pallas Health is best for patients who want a clinician to choose between a brand-name pen and a per-patient compounded preparation and who accept cash-pay pricing and 12-week compounded renewals. Eden Health is presented as best for people who prefer simple monthly billing with a lifetime price guarantee and clear monthly prices at every dose. Both require clinician eligibility determinations for treatment.
View Eden Health program details and eligibility
Conclusion: Pallas Health vs Eden Health
In the Pallas Health vs Eden Health comparison, Pallas emphasizes clinician choice between brand and compounded products, an all-in plan price including care, and 12-week compounded renewals with a $139 intro for compounded semaglutide. Eden emphasizes fixed monthly pricing from $99 for semaglutide and $129 for tirzepatide, free expedited shipping and a lifetime price guarantee. Confirm current pricing, eligibility and state availability with each provider before enrolling because some details may change.
Choose Pallas Health if you want clinician-selected access to FDA-approved pens or US-compounded GLP-1s with provider care included in the plan price. Choose Eden Health if you want a clear monthly price guaranteed for life and straightforward monthly billing at the published semaglutide or tirzepatide rates.